GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HHSO100201300004CROMARK LABORATORIES, L.C.

Overview

Award facts

Net obligations
$70.75M
$70,748,205of $70.75M potential value
Period of performance
Feb 28, 2013 to Dec 31, 2015
Ended
Modifications
10
Latest action Dec 31, 2024
Contract type
Definitive contract
PIID HHSO100201300004C

Description of requirement

IGF::OT::IGF ADVANCED DEVELOPMENT OF NITAZOXANIDE, ADMINISTERED ALONE OR IN COMBINATION WITH OSELTAMIVIR, FOR TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA VIRUS INFECTION IN ADULTS AND PEDIATRIC PATIENTS AT LEAST 12 YEARS OF AGE

Dates and value

Award date
Signed on Feb 27, 2013
Potential end of performance
Dec 30, 2015
Current value
$70,748,205Base and exercised options
Potential value (if all options are exercised)
$70,748,205

Obligations by fiscal year of action

  • FY2025: -$4,353,830 (de-obligation)
  • FY2014: $31,009,581
  • FY2013: $44,092,454

Total across 3 fiscal years: $70,748,205

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 31, 2024. View on USAspending · Recipient on SAM.gov

Recipient

LocationTAMPA, FL
UEIGJA6RDFXCEJ3
CAGE code3NDS6
Business sizeSmall businessSize at award, per the contracting officer

Business types and certifications

For-profit organizationLimited liability companyManufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Office Of Assistant Secretary For Preparedness And Response
  3. BARDA - ASPR / DAAPPO / BARDA DCMA
Funded from
Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)

Place of performance

Place of performance
Tampa, Hillsborough, Florida 33607-1400
Congressional district (place of performance)
FL-14As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
6

Contract details

Subcontracting plan
Plan not requiredB
Major program
Advanced development of nitazoxanide, administered alone or in combination with oseltamivir, for tre
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
Yes
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Feb 27, 2013Base obligation at award: $44,092,454
Latest action
Dec 31, 2024 — CloseoutModification P00010; obligation change -$4,353,830; administrative: no change in scope or value
Latest substantive action
Jul 13, 2015 — Supplemental agreement (within scope)Modification 9
Actions by type
  • Base award1
  • Supplemental agreement (within scope)6
  • Other administrative action3
  • Closeout1
11 actions recorded, Feb 27, 2013 to Dec 31, 2024; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$4,353,830
Latest action: change in base and all options
-$4,353,830

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7505
Contracting office code
75A501
Transactions recorded under this award key
11

Funding

Funding agency code
7500
Funding sub-tier code
7505
Funding office code
75A501
Treasury accounts
  • 075-X-0140-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression